Art

J-GLOBAL ID：202002279933622277   Reference number：20A0995793

Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis

トランスチレチン心臓アミロイドーシスによる重症心不全に対するピモベンダンの有益な効果

Author (9)： Okamoto Nao (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Kubo Toru (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Nakashima Yasuteru (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Ochi Yuri (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Takahashi Asa (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Baba Yuichi (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Hirota Takayoshi (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Yamasaki Naohito (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan) ,  Kitaoka Hiroaki (Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 59  Issue： 3  Page： 339-343(J-STAGE)  Publication year： 2020 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： severe heart failure ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0995793&from=J-GLOBAL&jstjournalNo=U0033A") }}

Author keywords (3)： transthyretin amyloid cardiomyopathy ,  heart failure ,  pimobendan

JST classification (2)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M) ,  Clinical application of cardioactive drugs  (GW07030Y)

Substance index (1)： Pimobendan

Reference (8)：

• 1. González-López E, Gallego-Delgado M, Guzzo-Merello G, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36: 2585-2594, 2015.
• 2. Mohammed SF, Mirzoyev SA, Edwards WD, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2: 113-122, 2014.
• 3. Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 135: 1357-1377, 2017.
• 4. Gertz MA, Benson MD, Dyck PJ, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol 66: 2451-2466, 2015.
• 5. Izumiya Y, Takashio S, Oda S, Yamashita Y, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. J Cardiol 71: 135-143, 2018.

Terms in the title (4)： トランスチレチン ,  心臓アミロイドーシス ,  重症心不全 ,  ピモベンダン